Latest Chemotherapy news
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine
posted July 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
KRAS ctDNA Linked to Worse Overall Survival in Localized Pancreatic Cancer
posted July 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cancer Drug Shortage Renews Calls For Federal Action
posted June 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Oral Drug Combo Effective for Older Patients With Acute Myeloid Leukemia
posted June 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer 
Study IDs Dementia Risk Factors in Those Older Than 90 Years 
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race 
Mental Distress, Fatigue Common in Childhood Survivors of Leukemia, Lymphoma Related Articles
.jpg)
Health Consequences Vary by Chemo Regimen in Testicular Cancer Survivors 
Immunochemotherapy Infusions Early in the Day Tied to Improved NSCLC Survival 
Addition of Palbociclib Improves PFS in HR-Positive, HER2-Positive Metastatic Breast Cancer 
Progression-Free Survival Prolonged With Sacituzumab Govitecan Plus Pembrolizumab in TNBC Monthly Specialist Briefings
Stay Connected
